Salvage Chemotherapy for Poor Prognosis Germ Cell Tumors - A Phase I-II Sequential Chemotherapy Protocol of Bevacizumab (Avastin) Plus High-dose ICE (Ifosfamide - Carboplatin - Etoposide) Intensification
Phase of Trial: Phase I/II
Latest Information Update: 25 Feb 2019
Price : $35 *
At a glance
- Drugs Bevacizumab (Primary) ; Autologous stem cell therapy; Carboplatin; Etoposide; Filgrastim; Ifosfamide
- Indications Germ cell and embryonal neoplasms
- Focus Adverse reactions; Therapeutic Use
- Acronyms TAXIF III
- 18 Feb 2019 Planned End Date changed from 1 Sep 2018 to 1 Sep 2020.
- 18 Feb 2019 Planned primary completion date changed from 1 Mar 2018 to 1 Mar 2019.
- 07 Dec 2017 Planned End Date changed from 1 Sep 2017 to 1 Sep 2018.